Investment Analysts’ downgrades for Tuesday, October 27th:
Abbott Laboratories (NYSE:ABT) was downgraded by analysts at Argus from a buy rating to a hold rating.
Artiva Biotherapeutics (NASDAQ:ARTV) was downgraded by analysts at Wedbush from an outperform rating to a neutral rating. Wedbush currently has $4.00 price target on the stock.
Artiva Biotherapeutics (NASDAQ:ARTV) was downgraded by analysts at Needham & Company LLC from a buy rating to a hold rating.
Badger Meter (NYSE:BMI) was downgraded by analysts at Northcoast Research from a buy rating to a neutral rating.
Bank of Hawaii (NYSE:BOH) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. Keefe, Bruyette & Woods currently has $78.00 price target on the stock, down from their previous price target of $85.00.
Intergroup (NASDAQ:INTG) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Mercer International (NASDAQ:MERC) (TSE:MRI.U) was downgraded by analysts at Canadian Imperial Bank of Commerce from a neutral rating to a sector underperform rating.
Moderna (NASDAQ:MRNA) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.
Onespan (NASDAQ:OSPN) was downgraded by analysts at Rosenblatt Securities from a buy rating to a neutral rating. Rosenblatt Securities currently has $18.00 price target on the stock.
PagSeguro Digital (NYSE:PAGS) was downgraded by analysts at Citigroup from a buy rating to a neutral rating. They currently have $8.00 target price on the stock.
UWM (NYSE:UWMC) was downgraded by analysts at Compass Point from a buy rating to a neutral rating. Compass Point currently has $1.50 price target on the stock.
Varonis Systems (NASDAQ:VRNS) was downgraded by analysts at Stephens from an overweight rating to an equal weight rating.
XP (NASDAQ:XP) was downgraded by analysts at Citigroup from a buy rating to a neutral rating. They currently have $15.00 target price on the stock.
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
